Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer

Clinical trial NCT02830594 · COMPLETED

Trial details

NCT number: NCT02830594
Sponsor: City of Hope Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Adenocarcinoma Gastric Squamous Cell Carcinoma Gastroesophageal Junction Adenocarcinoma Metastatic Malignant Neoplasm in the Stomach Stage IV Esophageal Adenocarcinoma AJCC v7 Stage IV Esophageal Squamous Cell Carcinoma AJCC v7

Start date: 2016-10-05
Primary completion: 2022-01-20
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.